Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - SHORT-TERM DEBT
Short-term Debt VRDN - Viridian Therapeutics, Inc.
843 K
LAST VALUE
27.32%
2 YEAR CAGR
-18.14%
5 YEAR CAGR
1.92%
10 YEAR CAGR